Key Safety Differentiators No IGF-1 elevation: AOD-9604 does not stimulate IGF-1, meaning it avoids risks such as organ/tissue overgrowth or acromegaly No glucose disruption: Clinical data shows it does not impair insulin sensitivity or worsen blood sugar regulation Comparable to placebo: In obesity trials, the incidence of adverse effects was similar to placebo groups, underscoring its tolerability Legal Status of AOD-9604 United States: AOD-9604 is not FDA-approved as a drug, dietary supplement, or weight loss therapy
Audits can take various forms, from unannounced spot checks to formal, scheduled reviews
Early work focused on the hGH fragment 177191, which was later modified by adding a tyrosine residue, leading to the development of AOD 9604
Flexible Spending Accounts (FSA), Health Savings Accounts (HSA), all major credit cards, cash discount of 3%, and Care Credit Milwaukee residents are discovering the immediate benefits of vitamin B12 injections at Restore Wellness Collective, a premier medspa specializing in comprehensive wellness solutions